Ondine presents nasal infection prevention data at UK conference

BIRMINGHAM - Ondine Biomedical Inc. (LON:OBI) presented clinical data on its Steriwave nasal photodisinfection technology at the Infection Prevention and Control Conference held Monday and Tuesday at The National Conference Centre in Birmingham. Dr. Nicolas Loebel, the company’s President and Chief Technology Officer, delivered a presentation titled "Nasal Photodisinfection: Addressing the Hidden Costs of HAIs" to clinicians, infection prevention specialists, and NHS decision-makers, according to a press release statement. The presentation focused on healthcare-associated infections and nasal decolonization strategies. Ondine reported that data from Steriwave use in Canada and the UK showed reductions in surgical site infections and ICU-acquired pneumonia.

…

Excerpt limited to ~120 words for fair-use compliance. The full article is at Investing.com — News.